Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?

Oncology in Clinical Practice - Poland
doi 10.5603/ocp.2018.0054
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

VM Media SP. zo.o VM Group SK

Related search

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

Cancers
Cancer ResearchOncology
2019English

Why Do We Need a New Library Science

Bibliothek Forschung und Praxis
2018English

Why Do We Need Memory?

Theatrical Colloquia
2019English

Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2015English

Why We Need a New Clinical Method

Scandinavian Journal of Primary Health Care
EnvironmentalPublic HealthOccupational Health
1993English

‘Why Do We Need Your Research?’

Journal of Extreme Anthropology
2020English

Why Do We Need Another Journal?

npj Quantum Materials
OpticalElectronicCondensed Matter PhysicsMagnetic Materials
2016English

Why Do We Need a New Open Access Journal Devoted to Microbiology?

Microbiology Independent Research journal
2014English

Autophagy Modulation in MEK Inhibitor-Resistant Melanoma

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy